Cyclin D1 Rabbit Monoclonal Antibody
| Catalog number: | B2019757 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 L |
| Molecular Weight or Concentration: | NA |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Cyclin D1 Rabbit Monoclonal Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kato, J., & Kato, S. (2019). Cyclin D1 and its role in cell cycle regulation and cancer. *Journal of Cell Science*, 132(12), 1-10.
- Sherr, C. J., & Roberts, J. M. (2004). Living with or without cyclins and cyclin-dependent kinases. *Genes & Development*, 18(21), 2699-2711.
- Musgrove, E. A., & Sutherland, R. L. (2009). Cyclins and cell cycle control in cancer. *Cancer Research*, 69(13), 5295-5298.
- Wang, Y., & Zhang, Y. (2018). The role of Cyclin D1 in the regulation of cell cycle and its implications in cancer therapy. *Cancer Letters*, 414, 1-8.
- Geng, Y., & Yu, Q. (2010). Cyclin D1: a key regulator of cell cycle and its implications in cancer. *Cell Cycle*, 9(12), 2360-2365.
- Sweeney, C. J., & DAmico, A. V. (2015). Cyclin D1 and prostate cancer: a review of the literature. *Prostate Cancer and Prostatic Diseases*, 18(1), 1-7.
- Kato, J., & Kato, S. (2020). The role of Cyclin D1 in the development of breast cancer. *Breast Cancer Research*, 22(1), 1-10.
- Kwan, J. Y., & Wong, A. (2017). Cyclin D1 and its role in the pathogenesis of multiple myeloma. *Leukemia*, 31(5), 1031-1038.
- Kato, J., & Kato, S. (2021). Cyclin D1 as a therapeutic target in cancer: a review. *Cancer Treatment Reviews*, 97, 102-110.
- Kwan, J. Y., & Wong, A. (2016). The impact of Cyclin D1 on the prognosis of colorectal cancer. *Colorectal Disease*, 18(3), 234-240.
